complex interaction between genetic, environmental,
metabolic, dietary, and behavioral factors.
0007 The pathogenesis of obesity can be considered the
sum of those biological factors, which increase the
predisposition towards expansion of adipose tissue
mass together with consequences of adaptation to
an environment that promotes and possibly rewards
increased food intake and decreased physical
activity.
0008 When daily energy intake is equal to daily energy
expenditure, a state of energy balance exists, and the
body weight stays constant. When energy intake
exceeds energy expenditure, a state of positive energy
balance exists, and body weight increases. Over-
weight and obesity are usually the result of months
and years of positive energy balance, resulting in
enlargement of fat cells.
Genetic Factors
0009 It has long been appreciated that obesity runs in
families. Familial studies confirm that BMI is highly
correlated among first-degree relatives.
0010 Twin studies have shown a similarity in BMI be-
tween twins, which is stronger in monozygotic than in
dizygotic twins. This correlation was found to persist
even when the twins were raised separately.
0011 Adoption studies have shown a significant correl-
ation between the BMI of biological parents and
adoptees, but not between the BMI of adoptive
parents and adoptees. These studies suggest that the
heritability of obesity may be as low as 10% (adop-
tion studies) to as high as 80% (twin studies).
0012 Some of the most compelling evidence for the gen-
etic basis of obesity comes from the discovery of five
mutations that cause spontaneous obesity and dia-
betes in mice. The Agouti (Ay), obese (ob), fat,
diabetes (db) and tubby (tub) genes have all been
cloned. In 1994, the discovery of the ob gene and its
product leptin in ob/ob mice was a significant ad-
vancement in our understanding of the genetics of
body-weight regulation. Since then, substantial pro-
gress has been made in characterizing genes related to
human obesity. Genes responsible for previously
existing mouse obesity mutations, Ay, db, ob, fat,
tub, have been identified and have led to an under-
standing of the physiological pathways underlying
each mutation.
0013 Leptin, for example, is a 16-kDa hormone pro-
duced by adipose tissue, which acts by binding to
receptors in the hypothalamus, which in turn alters
the expression of several neuropeptides that regulate
neuroendocrine function, appetite, and energy ex-
penditure. A decrease in body fat leads to a decreased
level of this hormone, which in turn stimulates food
intake. In addition, decreased leptin levels activate a
hormonal response that is characteristic of the starved
state, including reductions in the resting metabolic
rate. Increased body fat is associated with increased
levels of leptin, which act to reduce food intake. By
this mechanism, weight is maintained within a rela-
tively narrow range physiologically.
0014Mutation of the leptin gene, leading to deficiency
of leptin, results in the development of hyperpha-
gia, hypogonadotrophic hypogonadism, and severe
obesity with childhood onset (functionally equivalent
to the ob mouse model). So far, only two kindreds
with defects in leptin have been reported. In humans,
mutations have also been identified in the leptin
receptor in the hypothalamus (equivalent of the
db mouse model), in the melanocortin 4 receptor
(MC4R) and proopiomelanocortin (POMC), which
is a precursor for the natural ligand of MC4R (Agouti
model). Mutation in the prohormone and neuropep-
tide processing enzyme carboxypeptidase E in the fat
mouse model and its equivalent in human peptidase
PC1 have also been described.
0015Although monogenic mouse models have played an
important role in our understanding of the biology of
weight control, these mutations are rare and do not
explain the common genetic predisposition to obesity
seen in most human populations. They help us in
understanding why, within a relatively homogenous
environment, some individuals are lean and others
are obese. However, only a small fraction of human
obesity is due to a deficiency of leptin; instead,
human obesity is associated with increased plasma
concentrations of leptin. Thus, human obesity is char-
acterized by a central and/or peripheral resistance or
decreased responsiveness to leptin. The biological
effects of the daily peripheral administration of
recombinant human leptin in obese humans are cur-
rently being determined in clinical trials but are not
expected to be dramatic, considering the nonrespon-
siveness to the satiety effects of high physiologic levels
of leptin in obese individuals.
0016So far, more than 30 syndromes with a Mendelian
pattern of inheritance associated with obesity have
been identified. Most of these are pleiotropic syn-
dromes in which obesity is one of the several features.
0017Prader–Willi syndrome (PWS) is the most common
and best-characterized human obesity syndrome with
an estimated prevalence of 1:25 000 and autosomal
dominant pattern of inheritance. In addition to
obesity, it is characterized by hypotonia at birth,
small hands and feet, hyperphagia that usually
develops between 12 and 18 months of age, mental
retardation, short stature, and hypogonadism. Al-
though familial inheritance of PWS is sometimes
described, the vast majority of cases are sporadic. It
has been established that PWS is most often caused by
OBESITY/Etiology and Diagnosis 4221